BIB

Conviction 29Scan · Fri, Oct 9, 2026

Bearish marubozu

ProShares Ultra NASDAQ Biotechnology (BIB) closed at $108.63 (+3.44%) on Oct 9, 2026. Its latest daily candle is a bearish marubozu. Price is below its 50-day and above its 200-day moving average. RSI(14) 45, RS Rating 91, -13.9% from its 52-week high, +36.4% year to date.

BIB$108.63+3.44%

ResistanceSupportVol 14

Vol MA14 90.15K

Jul 14Jul 30Aug 18Sep 3Sep 23Oct 9

ProShares Ultra NASDAQ Biotechnology

Price108.63

Change+3.44%

Gap+4.18%

Rel volume—

Avg volume64.66K

Avg $ vol7.04M

SMA 20111.63

SMA 50112.45

SMA 20092.59

Price vs 50-3.40%

Price vs 200+17.32%

MA stackmixed

50/200 cross—

Supertrenddown · 116.69

RSI (14)45

MACD hist-0.87

MACD crossbear · 6d

Stoch %K / %D44 / 28

ADX (14)15

+DI / −DI20 / 29

RSI divergence—

MACD divergence—

ATR %3.85%

ADR %3.01%

52w high126.22

52w low63.83

From 52w high-13.93%

Above 52w low+70.18%

New 52w highNo

SqueezeOff

Bollinger width11.82%

%B0.27

Donchian pos44.13%

Donchian high118.15

Donchian low101.11

AVWAP (52w high)110.63

vs AVWAP high-1.81%

AVWAP (52w low)93.64

vs AVWAP low+16.01%

OBV trendUp

Chaikin MF (20)-0.89

Today vs 20d—

Avg vol (14d)90.15K

Avg vol (20d)64.66K

Avg $ vol (20d)7.04M

Market cap—

RS Rating91 / 99

RS 3m (vs SPY)+4.84%

RS 6m (vs SPY)+18.60%

RS line new highNo

Trend template7/8

Technical rank76.1

1 week-1.07%

1 month-0.88%

3 months+8.76%

6 months+33.18%

1 year+65.66%

YTD+36.41%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value—

Revenue—

Net income—

Gross profit—

Free cash flow—

Industry—

ExchangeXNAS

Shares out870K

Employees—

ListedTue, Apr 6, 2010

Free float—

Float %—

Short interest8.81K

Days to cover0.5d

Short volume53.3%

Squeeze score19 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction29 / 100

Pattern quality—

Tech rank76.1 / 100

Group rank—

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBearish marubozu

Congress activity

Disclosed STOCK Act trades in BIB

All disclosures →

No recent disclosed trades by Congress in BIB. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in BIB

No recent insider (Form 4) filings in BIB. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in BIB

EDGAR →

No recent SEC filings on file for BIB.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.